2022 Q1 Form 10-Q Financial Statement
#000182912622012883 Filed on June 03, 2022
Income Statement
Balance Sheet
Concept | 2022 Q1 | 2021 Q1 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $151.0K | |
YoY Change | ||
Cash & Equivalents | $151.0K | |
Short-Term Investments | ||
Other Short-Term Assets | ||
YoY Change | ||
Inventory | ||
Prepaid Expenses | ||
Receivables | ||
Other Receivables | ||
Total Short-Term Assets | $151.0K | |
YoY Change | ||
LONG-TERM ASSETS | ||
Property, Plant & Equipment | ||
YoY Change | ||
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | $149.6K | |
YoY Change | ||
Total Long-Term Assets | $149.6K | |
YoY Change | ||
TOTAL ASSETS | ||
Total Short-Term Assets | $151.0K | |
Total Long-Term Assets | $149.6K | |
Total Assets | $300.6K | |
YoY Change | ||
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | ||
YoY Change | ||
Accrued Expenses | $37.37K | |
YoY Change | ||
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $250.0K | |
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $287.4K | |
YoY Change | ||
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | |
YoY Change | ||
Other Long-Term Liabilities | ||
YoY Change | ||
Total Long-Term Liabilities | $0.00 | |
YoY Change | ||
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $287.4K | |
Total Long-Term Liabilities | $0.00 | |
Total Liabilities | $287.4K | |
YoY Change | ||
SHAREHOLDERS EQUITY | ||
Retained Earnings | ||
YoY Change | ||
Common Stock | $287.00 | |
YoY Change | ||
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $13.23K | |
YoY Change | ||
Total Liabilities & Shareholders Equity | $300.6K | |
YoY Change |
Cashflow Statement
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
USD | |
CY2021Q1 | YOTAU |
Basic And Diluted Weighted Average Shares Outstanding
BasicAndDilutedWeightedAverageSharesOutstanding
|
shares | |
CY2022Q1 | YOTAU |
Basic And Diluted Net Loss Per Share
BasicAndDilutedNetLossPerShare
|
||
CY2021Q1 | YOTAU |
Basic And Diluted Net Loss Per Share
BasicAndDilutedNetLossPerShare
|
||
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
USD | |
CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
USD | |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
USD | |
CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
USD | |
CY2021Q1 | YOTAU |
Payment Of Deferred Offering Costs
PaymentOfDeferredOfferingCosts
|
USD | |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
USD | |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
USD | |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
USD | |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
USD | |
CY2022Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
USD | |
CY2021Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
USD | |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
USD | |
CY2021Q1 | YOTAU |
Deferred Offering Costs In Accrued Offering Expenses
DeferredOfferingCostsInAccruedOfferingExpenses
|
USD | |
CY2021Q1 | YOTAU |
Deferred Offering Costs Paid By Related Party
DeferredOfferingCostsPaidByRelatedParty
|
USD | |
CY2022Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
287 | USD |
CY2021Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
287 | USD |
CY2022Q1 | YOTAU |
Basic And Diluted Weighted Average Shares Outstanding
BasicAndDilutedWeightedAverageSharesOutstanding
|
2499999 | shares |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
13231 | USD |